25 October 2017 - Former governor-general Dame Quentin Bryce has backed efforts to have a life-extending breast cancer drug that costs $5000 a month listed on the PBS and made cheaper as she returned to Canberra to support the third annual Pink Lady luncheon.
The luncheon at the National Gallery of Australia heard Breast Cancer Australia Network chief executive officer Christine Nolan outline attempts by the network to lobby federal politicians to list ribociclib and palbociclib which belong to a new class of drugs called CDK4/6 inhibitors.
BCNA has been advocating strongly for the CDK inhibitors to be listed on the PBS so that Australian women who can benefit from the drugs can access them at an affordable price.